Novel substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US-2023008022-A1 · Jan 12, 2023 · US
This page is not indexed by search engines while we improve data quality.
He Shuwen patents
He Shuwen holds 18 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 18 |
| Recent patents | 0 |
| First publication | Sep 3, 2015 |
| Latest publication | Jan 12, 2023 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
[3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
US-11267786-B2 · Mar 8, 2022 · US
Antidiabetic heterocyclic compounds
US-11072602-B2 · Jul 27, 2021 · US
Novel [3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
US-2021214308-A1 · Jul 15, 2021 · US
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
US-11034661-B2 · Jun 15, 2021 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Novel substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US-2023008022-A1 · Jan 12, 2023 · US
[3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
US-11267786-B2 · Mar 8, 2022 · US
Antidiabetic heterocyclic compounds
US-11072602-B2 · Jul 27, 2021 · US
Novel [3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
US-2021214308-A1 · Jul 15, 2021 · US
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
US-11034661-B2 · Jun 15, 2021 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 18 |
| Chemistry & Metallurgy | 18 |
| Cross-Sectional Technologies | 4 |